Revolution Medicines price target set at $255 by Morgan Stanley
Morgan Stanley initiated a $255.00 per-share price target for Revolution Medicines. Benzinga also reported the firm initiated the stock at Overweight.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.